tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2025 Apr;19(4):e70112.
doi: 10.1111/irv.70112. SARS-CoV-2 Anti-S an Anti-N IgG Seropositivity in Children and Young People (1-24 Years) According to HIV Status in Lomé (Togo) in 2022
Yao Rodion Konu[SUP] 1 2 [/SUP], Florence Damond[SUP] 3 [/SUP], I Wone Oumarou Adama[SUP] 2 [/SUP], Valentine Marie Ferré[SUP] 3 [/SUP], Alassane Ouro-Médéli[SUP] 4 [/SUP], Ounoo Elom Takassi[SUP] 5 [/SUP], Nina Dapam[SUP] 6 [/SUP], Magnoulélén N'zonou[SUP] 7 [/SUP], Ridwane Bawa-Kawte[SUP] 8 [/SUP], Martin Kouame Tchankoni[SUP] 1 [/SUP], Arnold Junior Sadio[SUP] 1 2 [/SUP], Fatoumata Binta Tidiane Diallo[SUP] 9 [/SUP], Claver Anoumou Dagnra[SUP] 4 [/SUP], Charlotte Charpentier[SUP] 3 [/SUP], Didier Koumavi Ekouevi[SUP] 1 2 [/SUP]
Affiliations
We aimed to estimate SARS-CoV-2 seropositivity among children and young people in Lomé, Togo, according to HIV status. A multicenter comparative cross-sectional study was conducted, and 636 participants were included (41.8% living with HIV). Anti-S (88.7% vs. 89.1%) and anti-N (41.6% vs. 39.5%) IgG seropositivity were comparable in both groups. These data suggest no increased COVID-19 susceptibility in children and young people with HIV.
Keywords: HIV; SARS‐CoV‐2; seropositivity; young people.
. 2025 Apr;19(4):e70112.
doi: 10.1111/irv.70112. SARS-CoV-2 Anti-S an Anti-N IgG Seropositivity in Children and Young People (1-24 Years) According to HIV Status in Lomé (Togo) in 2022
Yao Rodion Konu[SUP] 1 2 [/SUP], Florence Damond[SUP] 3 [/SUP], I Wone Oumarou Adama[SUP] 2 [/SUP], Valentine Marie Ferré[SUP] 3 [/SUP], Alassane Ouro-Médéli[SUP] 4 [/SUP], Ounoo Elom Takassi[SUP] 5 [/SUP], Nina Dapam[SUP] 6 [/SUP], Magnoulélén N'zonou[SUP] 7 [/SUP], Ridwane Bawa-Kawte[SUP] 8 [/SUP], Martin Kouame Tchankoni[SUP] 1 [/SUP], Arnold Junior Sadio[SUP] 1 2 [/SUP], Fatoumata Binta Tidiane Diallo[SUP] 9 [/SUP], Claver Anoumou Dagnra[SUP] 4 [/SUP], Charlotte Charpentier[SUP] 3 [/SUP], Didier Koumavi Ekouevi[SUP] 1 2 [/SUP]
Affiliations
- PMID: 40275516
- PMCID: PMC12022004
- DOI: 10.1111/irv.70112
We aimed to estimate SARS-CoV-2 seropositivity among children and young people in Lomé, Togo, according to HIV status. A multicenter comparative cross-sectional study was conducted, and 636 participants were included (41.8% living with HIV). Anti-S (88.7% vs. 89.1%) and anti-N (41.6% vs. 39.5%) IgG seropositivity were comparable in both groups. These data suggest no increased COVID-19 susceptibility in children and young people with HIV.
Keywords: HIV; SARS‐CoV‐2; seropositivity; young people.